Laurus Labs joins Dow Jones Best-in-Class Indices
Laurus Labs has been included in the Dow Jones Best-in-Class (DJ BIC) World Index for the first time, reflecting its strong ESG performance. The company achieved an S&P Global CSA score of 81 out of 100 in the pharmaceutical category, up from 71 the previous year.
*this image is generated using AI for illustrative purposes only.
Laurus Labs has been included in the Dow Jones Best-in-Class (DJ BIC) World Index for the first time. This inclusion highlights the company's commitment to sustainable and ethical corporate governance practices. The DJBIC World Index ranks top-performing companies globally with strong ESG performance.
The company was previously featured in the S&P Global Sustainability Yearbook 2026, which ranks the world's most sustainable companies. Laurus Labs achieved an S&P Global Corporate Sustainability Assessment (CSA) score of 81 out of 100 in the category of pharmaceutical companies, an improvement from the previous year's score of 71 out of 100.
The Dow Jones Best-in-Class Indices identify and recognize companies that demonstrate exceptional performance across key Environmental, Social, and Governance (ESG) parameters. This recognition is based on leading S&P Global CSA scores.
Inclusion in DJ BIC indices reinforces Laurus Labs's credibility with global investors. It places the company among a distinguished group of global leaders recognized for best-in-class sustainability performance.
| Metric | Score |
|---|---|
| S&P Global CSA Score (Current Year) | 81 out of 100 |
| S&P Global CSA Score (Previous Year) | 71 out of 100 |
| Category | Pharmaceutical Companies |
This milestone reflects the dedication of the team at Laurus Labs to its core values of science-driven, responsible, and sustainable business practices.
Historical Stock Returns for Laurus Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.72% | -0.62% | +12.81% | +36.07% | +107.92% | +124.86% |
How might Laurus Labs' inclusion in the DJ BIC World Index influence its ability to attract ESG-focused institutional investors and impact its stock valuation in the near term?
Could this improved ESG standing give Laurus Labs a competitive advantage in securing partnerships or contracts with multinational pharmaceutical companies that prioritize sustainable supply chains?
What specific environmental or social initiatives might Laurus Labs need to pursue to further improve its CSA score beyond 81 and potentially achieve a top-tier ranking within the pharmaceutical category?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
